UTHR — UNITED THERAPEUTICS CORP DEL

Ownership history in STEMPOINT CAPITAL LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in UNITED THERAPEUTICS CORP DEL (UTHR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.53% (2025 Q3)
Avg. % of fund
0.26%
First filed
2024 Q1
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 6,264 -3,736 -37.4% 0.53% $2.6M $419.21
2024 Q1 INITIATED 10,000 — — 0.00% $11K —
% of Fund (quarterly)    UTHR price (monthly, adj. close)

Other funds also holding UTHR

As of 2025 Q4 — sorted by position size

Krensavage Asset Management, LLC 3Y 7Y 15.71% Avoro Capital Advisors LLC 3Y 7Y 12.48% Tri Locum Partners LP 3Y 7.65% Nepsis Inc. 3Y 7Y 6.59% Eversept Partners, LP 3Y 7Y 6.2% Summit Street Capital Management, LLC 3Y 7Y 4.36% Polaris Capital Management, LLC 3Y 7Y 4.19% Nitorum Capital, L.P. 3Y 7Y 3.99% Palo Alto Investors LP 3Y 7Y 3.95% First Turn Management, LLC 3.54%
← Back to STEMPOINT CAPITAL LP Holdings